Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-DUO 302: Irbesartan and Amlodipine in Essential Hypertension
NCT05475665Phase 3Completed
- Sponsor
- Handok
- Start
- Jul 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irbesartan + amlodipine in essential hypertension, sponsored by Handok. Started Jul 2022; status: completed.
02
Drugs
irbesartan + amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT05475665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05475665.